Vous n'êtes pas connecté(e)
33
2
Mablink Bioscience
Société
|
France
1
abonnés
Onglets principaux
A propos de votre organisation
Mablink Bioscience is a French-based biotechnology company founded in 2018 developing 3rd generation Antibody-drug Conjugates (ADC) based on proprietary drug-linker technologies.
The founding members gather a unique continuum of skills in chemistry, pharmacology and immunology to develop a hydrophilic easy-to-implement platform for next-generation ADCs.
With our technology platform, we are democratizing the use of ADCs in the clinic to improve patient care in the immuno-oncology field.
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.